We've found
3,204
archived clinical trials in
Healthy Studies
We've found
3,204
archived clinical trials in
Healthy Studies
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Updated: 2/19/2016
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus
Updated: 2/19/2016
Phase I Evaluation of a CMV-MVA Triplex Vaccine: Safety and Biologically Effective Dose in Healthy Volunteers With or Without Prior Immunity to CMV and Vaccinia
Status: Enrolling
Updated: 2/19/2016
Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus
Updated: 2/19/2016
Phase I Evaluation of a CMV-MVA Triplex Vaccine: Safety and Biologically Effective Dose in Healthy Volunteers With or Without Prior Immunity to CMV and Vaccinia
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy Participants
Updated: 2/19/2016
An Open-Label Drug Interaction Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on the Single-Dose Pharmacokinetics of Midazolam and the Single Dose Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Status: Enrolling
Updated: 2/19/2016
A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy Participants
Updated: 2/19/2016
An Open-Label Drug Interaction Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on the Single-Dose Pharmacokinetics of Midazolam and the Single Dose Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Impact of Cashew Nuts in the Human Diet: Measured Energy Value and Effects on Cardiovascular Disease Risk Factors
Status: Enrolling
Updated: 2/19/2016
Updated: 2/19/2016
Impact of Cashew Nuts in the Human Diet: Measured Energy Value and Effects on Cardiovascular Disease Risk Factors
Status: Enrolling
Updated: 2/19/2016
Updated: 2/19/2016
Click here to add this to my saved trials
A Pharmacokinetic Study on Co-administration of Tamiflu (Oseltamivir) and Rimantadine in Healthy Volunteers
Updated: 2/19/2016
An Open-label, Multiple Dose, Randomized, Three-period Crossover Study in Healthy Subjects to Evaluate the Effect of Co-administration of Oseltamivir (Ro 64-0796) 75 mg Twice Daily and Rimantadine 100 mg Twice Daily on the Pharmacokinetic Properties of Oseltamivir and Rimantadine.
Status: Enrolling
Updated: 2/19/2016
A Pharmacokinetic Study on Co-administration of Tamiflu (Oseltamivir) and Rimantadine in Healthy Volunteers
Updated: 2/19/2016
An Open-label, Multiple Dose, Randomized, Three-period Crossover Study in Healthy Subjects to Evaluate the Effect of Co-administration of Oseltamivir (Ro 64-0796) 75 mg Twice Daily and Rimantadine 100 mg Twice Daily on the Pharmacokinetic Properties of Oseltamivir and Rimantadine.
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility
Updated: 2/19/2016
Magnetic Resonance (MR) Evaluation of the Effect of Erythromycin Upon Gastric and Small Bowel Motility
Status: Enrolling
Updated: 2/19/2016
Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility
Updated: 2/19/2016
Magnetic Resonance (MR) Evaluation of the Effect of Erythromycin Upon Gastric and Small Bowel Motility
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers
Updated: 2/22/2016
An Open-label Study to Evaluate the Effect of Diet on the Tolerability of FOS, a Commercially Available Prebiotic, in Healthy Volunteers
Status: Enrolling
Updated: 2/22/2016
A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers
Updated: 2/22/2016
An Open-label Study to Evaluate the Effect of Diet on the Tolerability of FOS, a Commercially Available Prebiotic, in Healthy Volunteers
Status: Enrolling
Updated: 2/22/2016
Click here to add this to my saved trials
Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C]-BI 207127 in Healthy Male Volunteers
Updated: 2/22/2016
Metabolite Profile, Excretion Balance and Pharmacokinetics of BI 207127 NA Combined With [14C]-BI 207127 NA in Healthy Adult Male Volunteers After an 800 mg Single Oral Solution Dose; a Phase I, Single-arm, Open-label Trial
Status: Enrolling
Updated: 2/22/2016
Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C]-BI 207127 in Healthy Male Volunteers
Updated: 2/22/2016
Metabolite Profile, Excretion Balance and Pharmacokinetics of BI 207127 NA Combined With [14C]-BI 207127 NA in Healthy Adult Male Volunteers After an 800 mg Single Oral Solution Dose; a Phase I, Single-arm, Open-label Trial
Status: Enrolling
Updated: 2/22/2016
Click here to add this to my saved trials
Psilocybin and Spiritual Practice
Updated: 2/23/2016
Effects of Psilocybin and Spiritual Practice on Persisting Changes in Attitudes and Behavior
Status: Enrolling
Updated: 2/23/2016
Psilocybin and Spiritual Practice
Updated: 2/23/2016
Effects of Psilocybin and Spiritual Practice on Persisting Changes in Attitudes and Behavior
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
Updated: 2/23/2016
The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
Status: Enrolling
Updated: 2/23/2016
The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
Updated: 2/23/2016
The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
CALERIE Phase II Ancillary: Metabolic
Updated: 2/24/2016
CALERIE Phase II Ancillary 2: Metabolic Adaptation After Two Years of Caloric Restriction in Non Obese Humans
Status: Enrolling
Updated: 2/24/2016
CALERIE Phase II Ancillary: Metabolic
Updated: 2/24/2016
CALERIE Phase II Ancillary 2: Metabolic Adaptation After Two Years of Caloric Restriction in Non Obese Humans
Status: Enrolling
Updated: 2/24/2016
Click here to add this to my saved trials
The Effect of AGE on the Immune System
Updated: 2/25/2016
The Effect of Aged Garlic Extract Supplementation on the Immune System
Status: Enrolling
Updated: 2/25/2016
The Effect of AGE on the Immune System
Updated: 2/25/2016
The Effect of Aged Garlic Extract Supplementation on the Immune System
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
The Effect of AGE on the Immune System
Updated: 2/25/2016
The Effect of Aged Garlic Extract Supplementation on the Immune System
Status: Enrolling
Updated: 2/25/2016
The Effect of AGE on the Immune System
Updated: 2/25/2016
The Effect of Aged Garlic Extract Supplementation on the Immune System
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease
Updated: 2/25/2016
Single- and Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY3202626
Status: Enrolling
Updated: 2/25/2016
A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease
Updated: 2/25/2016
Single- and Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY3202626
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem
Updated: 2/25/2016
Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem
Status: Enrolling
Updated: 2/25/2016
Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem
Updated: 2/25/2016
Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Neurobiological Bases of Paternal Nurturance
Updated: 2/26/2016
Biological Bases of Individual Variation in Paternal Nurturance
Status: Enrolling
Updated: 2/26/2016
Neurobiological Bases of Paternal Nurturance
Updated: 2/26/2016
Biological Bases of Individual Variation in Paternal Nurturance
Status: Enrolling
Updated: 2/26/2016
Click here to add this to my saved trials
Neurobiological Bases of Paternal Nurturance
Updated: 2/26/2016
Biological Bases of Individual Variation in Paternal Nurturance
Status: Enrolling
Updated: 2/26/2016
Neurobiological Bases of Paternal Nurturance
Updated: 2/26/2016
Biological Bases of Individual Variation in Paternal Nurturance
Status: Enrolling
Updated: 2/26/2016
Click here to add this to my saved trials
Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers
Updated: 2/26/2016
A First in Human Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Dose Levels of Trimeric gp140 Protein in Healthy Adult Volunteers
Status: Enrolling
Updated: 2/26/2016
Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers
Updated: 2/26/2016
A First in Human Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Dose Levels of Trimeric gp140 Protein in Healthy Adult Volunteers
Status: Enrolling
Updated: 2/26/2016
Click here to add this to my saved trials
Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers
Updated: 2/26/2016
A First in Human Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Dose Levels of Trimeric gp140 Protein in Healthy Adult Volunteers
Status: Enrolling
Updated: 2/26/2016
Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers
Updated: 2/26/2016
A First in Human Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Dose Levels of Trimeric gp140 Protein in Healthy Adult Volunteers
Status: Enrolling
Updated: 2/26/2016
Click here to add this to my saved trials
The Effect of Calorie Deprivation on Adipose Tissue Distribution
Updated: 2/27/2016
The Effect of Calorie Deprivation on Adipose Tissue Distribution
Status: Enrolling
Updated: 2/27/2016
The Effect of Calorie Deprivation on Adipose Tissue Distribution
Updated: 2/27/2016
The Effect of Calorie Deprivation on Adipose Tissue Distribution
Status: Enrolling
Updated: 2/27/2016
Click here to add this to my saved trials
Oral Contraceptive DDI Study
Updated: 2/29/2016
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and Ortho-Cyclen®, an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women
Status: Enrolling
Updated: 2/29/2016
Oral Contraceptive DDI Study
Updated: 2/29/2016
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and Ortho-Cyclen®, an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Oral Contraceptive DDI Study
Updated: 2/29/2016
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and Ortho-Cyclen®, an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women
Status: Enrolling
Updated: 2/29/2016
Oral Contraceptive DDI Study
Updated: 2/29/2016
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and Ortho-Cyclen®, an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants
Updated: 3/1/2016
Gene Environment Risk Assessment and CRC Screening
Status: Enrolling
Updated: 3/1/2016
Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants
Updated: 3/1/2016
Gene Environment Risk Assessment and CRC Screening
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers
Updated: 3/1/2016
A Phase I, Fixed Sequence, Open-label, Study to Assess the Pharmacokinetics of AZD9291 in Healthy Male Volunteers When a Single Oral Dose of AZD9291 80 mg is Administered Alone and in Combination With Omeprazole
Status: Enrolling
Updated: 3/1/2016
Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers
Updated: 3/1/2016
A Phase I, Fixed Sequence, Open-label, Study to Assess the Pharmacokinetics of AZD9291 in Healthy Male Volunteers When a Single Oral Dose of AZD9291 80 mg is Administered Alone and in Combination With Omeprazole
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers
Updated: 3/1/2016
A Phase I, Fixed Sequence, Open-label, Study to Assess the Pharmacokinetics of AZD9291 in Healthy Male Volunteers When a Single Oral Dose of AZD9291 80 mg is Administered Alone and in Combination With Omeprazole
Status: Enrolling
Updated: 3/1/2016
Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers
Updated: 3/1/2016
A Phase I, Fixed Sequence, Open-label, Study to Assess the Pharmacokinetics of AZD9291 in Healthy Male Volunteers When a Single Oral Dose of AZD9291 80 mg is Administered Alone and in Combination With Omeprazole
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Updated: 3/1/2016
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Status: Enrolling
Updated: 3/1/2016
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Updated: 3/1/2016
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Updated: 3/1/2016
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Status: Enrolling
Updated: 3/1/2016
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Updated: 3/1/2016
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Updated: 3/1/2016
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Status: Enrolling
Updated: 3/1/2016
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Updated: 3/1/2016
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
An Online Study of the Reliability of the Brain Performance Test (BPT)
Updated: 3/2/2016
An Online Study of the Reliability of the Brain Performance Test (BPT)
Status: Enrolling
Updated: 3/2/2016
An Online Study of the Reliability of the Brain Performance Test (BPT)
Updated: 3/2/2016
An Online Study of the Reliability of the Brain Performance Test (BPT)
Status: Enrolling
Updated: 3/2/2016
Click here to add this to my saved trials
Pre-analytical Sample Handling Conditions and Their Effects on the Human Serum Metabolome
Status: Enrolling
Updated: 3/2/2016
Updated: 3/2/2016
Pre-analytical Sample Handling Conditions and Their Effects on the Human Serum Metabolome
Status: Enrolling
Updated: 3/2/2016
Updated: 3/2/2016
Click here to add this to my saved trials
Single Ascending Dose Study of TD-0714 in Healthy Subjects
Updated: 3/3/2016
A Phase 1, Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD−0714 in Healthy Subjects
Status: Enrolling
Updated: 3/3/2016
Single Ascending Dose Study of TD-0714 in Healthy Subjects
Updated: 3/3/2016
A Phase 1, Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD−0714 in Healthy Subjects
Status: Enrolling
Updated: 3/3/2016
Click here to add this to my saved trials
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
Updated: 3/7/2016
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
Updated: 3/7/2016
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
Updated: 3/7/2016
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
Updated: 3/7/2016
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
Updated: 3/7/2016
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
Updated: 3/7/2016
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
Updated: 3/7/2016
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
Updated: 3/7/2016
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
Updated: 3/7/2016
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
Updated: 3/7/2016
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials